BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 2441394)

  • 21. Embryonic stem cells deficient in I beta1,6-N-acetylglucosaminyltransferase exhibit reduced expression of embryoglycan and the loss of a Lewis X antigen, 4C9.
    Muramatsu H; Kusano T; Sato M; Oda Y; Kobori K; Muramatsu T
    Glycobiology; 2008 Mar; 18(3):242-9. PubMed ID: 18184719
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Coordinate expression of parietal endodermal functions in hybrids of embryonal carcinoma and endodermal cells.
    Howe WE; Oshima RG
    Mol Cell Biol; 1982 Mar; 2(3):331-7. PubMed ID: 7202115
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differentiation in vitro of human-mouse teratocarcinoma hybrids.
    Benham FJ; Wiles MV; Goodfellow PN
    Mol Cell Biol; 1983 Dec; 3(12):2259-70. PubMed ID: 6686281
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Isolation of mutants showing temperature-sensitive cell growth from embryonal carcinoma cells: control of stem cell differentiation by incubation temperatures.
    Nishimune Y; Nishina Y; Sumi T; Kosaka M; Takeda M; Matsumoto K; Matsushiro A; Sakuda M
    Biochem Biophys Res Commun; 1989 Nov; 165(1):65-72. PubMed ID: 2574037
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cell-surface changes during in vitro differentiation of pluripotent embryonal carcinoma cells.
    Muramatsu H; Hamada H; Noguchi S; Kamada Y; Muramatsu T
    Dev Biol; 1985 Aug; 110(2):284-96. PubMed ID: 3894113
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Altered differentiation, indefinite growth potential, diminished tumorigenicity, and suppressed chimerization potential of hybrids between mouse teratocarcinoma cells and thymocytes.
    Martin GM; Ogburn CE; Au K; Disteche CM
    J Exp Pathol; 1984; 1(2):103-33. PubMed ID: 6599936
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Analysis of F9 embryonal carcinoma cell lactosaminoglycans in relation to their differential expression during induction of differentiation.
    Rusciano D; Terrana B
    Biochim Biophys Acta; 1988 Jan; 964(1):8-18. PubMed ID: 3334875
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Induced muscle differentiation in an embryonal carcinoma cell line.
    Edwards MK; Harris JF; McBurney MW
    Mol Cell Biol; 1983 Dec; 3(12):2280-6. PubMed ID: 6656767
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Analysis of a nontumorigenic embryonal carcinoma cell line.
    McCormick PJ; Shin HS
    Exp Cell Res; 1990 Aug; 189(2):183-8. PubMed ID: 2164481
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lectin-resistant CHO cells: selection of seven new mutants resistant to ricin.
    Stanley P; Sallustio S; Krag SS; Dunn B
    Somat Cell Mol Genet; 1990 May; 16(3):211-23. PubMed ID: 2360093
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Polyoma virus mutants as probes of variety among mouse embryonal carcinoma cell lines.
    Georges E; Vasseur M; Blangy D
    Differentiation; 1982; 22(1):62-5. PubMed ID: 6286399
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Polyoma mutants that productively infect F9 embryonal carcinoma cells do not rescue wild-type polyoma in F9 cells.
    Fujimura FK; Linney E
    Proc Natl Acad Sci U S A; 1982 Mar; 79(5):1479-83. PubMed ID: 6280185
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of polysaccharide synthesis between preimplantation stage mouse embryos and F9 embryonal carcinoma cells.
    Iwakura Y
    Exp Cell Res; 1983 Jul; 146(2):329-38. PubMed ID: 6873191
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characteristics of the interferon system of an embryonal carcinomal cell are recessive in intraspecific somatic cell hybrids.
    Veomett MJ; Veomett GE
    Somatic Cell Genet; 1980 May; 6(3):325-32. PubMed ID: 6157204
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Biochemical properties of the high-molecular-weight glycopeptides released from the cell surface of human teratocarcinoma cells.
    Muramatsu H; Muramatsu T; Avner P
    Cancer Res; 1982 May; 42(5):1749-52. PubMed ID: 6802482
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The stage-specific expression of TEC-1, -2, -3, and -4 antigens on bovine preimplantation embryos.
    Dowsing AT; Gougoulidis T; Dowsing BJ; Draber P; Trounson AO
    Mol Reprod Dev; 1998 Jan; 49(1):19-28. PubMed ID: 9406192
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Embryonal carcinoma cells (and their somatic cell hybrids) are resistant to infection by the murine parvovirus MVM, which does infect other teratocarcinoma-derived cell lines.
    Miller RA; Ward DC; Ruddle FH
    J Cell Physiol; 1977 Jun; 91(3):393-401. PubMed ID: 558990
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nullipotent teratocarcinoma cells acquire the pluripotency for differentiation by fusion with somatic cells.
    Atsumi T; Shirayoshi Y; Takeichi M; Okada TS
    Differentiation; 1982; 23(1):83-6. PubMed ID: 7152170
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gene expression of differentiated parent in teratocarcinoma cell hybrids. Repression or reprogramming?
    Forejt J; Gregorová S; Dohnal K; Nosek J
    Cell Differ; 1984 Dec; 15(2-4):229-34. PubMed ID: 6535645
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Production of insulin-like growth factor-II (MSA) by endoderm-like cells derived from embryonal carcinoma cells: possible mediator of embryonic cell growth.
    Nagarajan L; Anderson WB; Nissley SP; Rechler MM; Jetten AM
    J Cell Physiol; 1985 Aug; 124(2):199-206. PubMed ID: 4044654
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.